SB19 allows pharmacists to dispense ivermectin to adults under a standing order from a licensed healthcare professional authorized by the Department of Health. The department must set dispensing procedures through rulemaking. Pharmacies may charge an administrative fee in addition to normal costs, and pharmacists are granted civil immunity when acting in compliance with the law. Health insurers are not required to cover ivermectin dispensed under this provision.

The Louisiana State House of Representatives passed SB19 on June 6, 2025 by a vote of 67 to 26. We have assigned pluses to the ayes because this bill restores a measure of medical freedom that federal agencies and corporate media have spent years undermining. As The New American has documented, ivermectin was relentlessly attacked during Covid—despite strong safety records, widespread global use, and mounting evidence supporting its benefits—while federal regulators waged a public campaign to discourage doctors and patients from using a lawful medication. Empowering pharmacists to dispense ivermectin under a standing order pushes back against that politicized crusade, removes unnecessary barriers to care, and reinforces the principle that patients and healthcare professionals—not federal bureaucrats—should make treatment decisions.